REMINDER...PDF 50th Anniversary Symposium on Webcast
 

XShares Announces Availability of Parkinson Disease Foundation's 50th Anniversary Educational Symposium Webcast

Tuesday November 13, 4:30 pm ET
http://biz.yahoo.com/prnews/071113/nytu125.html?.v=101

HealthShares Neuroscience Exchange-Traded Fund Invests in a Portfolio of Companies Featuring 500 Neuroscience Products and Therapies

Excerpts:
NEW YORK, Nov. 13 /PRNewswire/ -- XShares Advisors LLC today announced the availability of a webcast of the Parkinson's Disease Foundation's 50th Anniversary Educational Symposium. The webcast, under editorial control of the Parkinson's Disease Foundation and supported exclusively by XShares, can be found at www.pdf.org/50th/webcast.cfm and offers more than twenty hours of presentations on the most seminal topics in Parkinson's basic and clinical research. XShares commenced a 12-month supporting relationship with the Parkinson's Disease Foundation in July 2007.

"We are pleased to provide public access to the valuable information offered in the symposium's webcast," said Robin Elliott, Parkinson's Disease Foundation's Executive Director. "With the support of XShares, the Parkinson's Disease Foundation is able to reach the global Parkinson's community with essential information on the most important topics in Parkinson's basic and clinical research."

About Parkinson's Disease Foundation

The Parkinson's Disease Foundation (PDF) is a leading national presence in Parkinson's disease research, education and public advocacy. We are working for the nearly one million people in the US living with Parkinson's by funding promising scientific research and supporting people with Parkinson's, their families and caregivers through educational programs and support services. Since its founding in 1957, PDF has funded over $70 million worth of scientific research in Parkinson's disease, supporting the work of leading scientists throughout the world.

An Investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. For this and more complete information about the fund call 800.925.2870 or visit the website www.healthsharesinc.com for a prospectus. Please read the prospectus carefully before investing.

-- There are risks involved with investing in ETFs including possible loss of money. HealthShares(TM) are not actively managed and are subject to risks similar to stocks, including those related to short selling and margin maintenance. Losses from short sales may be unlimited, and losses from purchases on margin may exceed original investment. HealthShares(TM) ETFs are subject to increased risks associated with investing in a specific sector compared to a more diversified investment, as well as unique risks associated with the healthcare and biotechnology sector (i.e., government regulation, patent regulation, etc.).

-- The ETFs face additional risks attributable to their investments in small and medium capitalization companies which are subject to higher volatility than larger, more established companies. In addition, they are invested in a limited number of securities and a decline in the value of these investments would cause the fund's overall value to decline to a greater degree than in a less concentrated portfolio.

-- Global or International Funds invest in foreign securities that will be subject to certain risks not associated with domestic securities, such as currency fluctuations, and changes in political and economic conditions.

The prospectus is not an offer to buy or sell the portfolio shares, nor is the fund soliciting an offer to buy its shares in any jurisdiction where the offer or sale is not permitted.

HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors,